SINGAPORE —MediThinQ , a Korean startup specialized in extended reality (XR) wearable displays tailored for surgical procedures, has hit a significant milestone as the first Asian startup to globally launch XR surgical displays. 

MediThinQ’s XR solutions use best-in-class image fidelity, latency, reliability, and equipment compatibility to present critical information directly in from of the surgeon’s eyes, eliminating the need to divert attention to screens. 

Mr Seungjoon Im, Founder & CEO of MediThinQ, expressed his excitement, stating, “We are proud of the groundbreaking technology we’ve cultivated over the past six years, which sets a new standard in the market. It’s even more rewarding to see our innovations making their way into operating theatres worldwide. 

 To fuel its international expansion efforts, MediThinQ  has successfully secured significant deals with industry giants, including Medtronic USA and Japan. 

In the United States and Japan, the world’s two largest healthcare markets, MediThinQ’s products will be exclusively distributed by Medtronic. 

MediThinQ further notes that the partnership with Medtronic not only enhances their reach but is an acknowledgement of the quality and effectiveness of its offerings. 

MediThinQ’s flagship products, Scopeye and MetaSCOPE, already hold regulatory approvals in key markets including the US (FDA), Europe (CE), Japan (PMDA), and Korea (KFDA). 

 The technology has also been recognised as one of the top winners at the Medtronic APAC Innovation Challenge in 2022 and received a gold medal at the 2023 Edison Awards. 

MediThinQ has also secured a multimillion-dollar investment from JLK Technology, a Singapore-headquartered medical devices manufacturer, who will also help accelerate MediThinQ’s mass production as its appointed manufacturer. 

Earlier this year, MediThinQ joined VentureBlick’s Super Incubator program, an initiative tailored to support healthcare startups through incubation, acceleration, and venture building.  

VentureBlick had played a pivotal role in enhancing MediThinQ’s global brand recognition, facilitating negotiations, raising funds, and positioning the company for continued success. 

MediThinQ’s flagship products, Scopeye and MetaSCOPE, had obtained regulatory approvals in key markets worldwide, including the US, Europe, Japan, and Korea.

Recognized for its innovation, the technology has received accolades such as the top winner at the Medtronic APAC Innovation Challenge in 2022 and a gold medal at the 2023 Edison Awards. 

MediThinQ’s commitment to advancing medical imaging equipment for surgery has positioned it as a leader in technological innovation, with strategic partnerships and regulatory approvals in place, poising it for further global expansion and success. 

Meanwhile, VentureBlick, a company that develops a healthcare transformation platform that effectively connects healthcare startups with verified medical investors, continued to drive healthcare innovation, connecting innovators, clinicians, investors, and ecosystem partners to create meaningful impact.  

 VentureBlick fostered collaboration and drove real-world medical advancements, for instance through the through its super incubator, consulting, and discovery programs, leveraging its extensive network of healthcare professionals and advisors globally. 

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.